Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Wuhui He"'
Autor:
Jintao Lou, Fan Wu, Wuhui He, Rui Hu, Ziyi Cai, Guisheng Chen, Wenji Zhao, Zhigang Zhang, Yu Si
Publikováno v:
Redox Report, Vol 29, Iss 1 (2024)
ABSTRACTCisplatin is widely employed in clinical oncology as an anticancer chemotherapy drug in clinical practice and is known for its severe ototoxic side effects. Prior research indicates that the accumulation of reactive oxygen species (ROS) plays
Externí odkaz:
https://doaj.org/article/3b674088334a49f2953a0cd41b00391c
Publikováno v:
NeuroToxicology. 95:218-231
Publikováno v:
Acta Oto-Laryngologica. 143:147-155
Autor:
Feinan He, Xiaotong Huang, Guokun Wei, Xiaorong Lin, Weijian Zhang, Wei Zhuang, Wuhui He, Ting Zhan, Hai Hu, Haidi Yang
Publikováno v:
Oxidative Medicine and Cellular Longevity. 2022:1-15
Cisplatin-induced ototoxicity is one of the common side effects during its treatment and there are no effective measures to prevent it. Our study aimed to investigate the effect of ACSL4-catalyzed lipid peroxidation on cisplatin-induced hearing loss
Autor:
Yiqing Zheng, Yongyi Ye, Haidi Yang, Ting Zhan, Wuhui He, Xin Min, Xiaotong Huang, Jiaqi Pang, Hao Xiong, Weijian Zhang, Feinan He, Zhengrong Liang, Bingquan Jian, Yiming Gao
Publikováno v:
Toxicology Letters. 349:115-123
Cisplatin, the most widely used platinum-based anticancer drug, often causes progressive and irreversible sensorineural hearing loss in cancer patients. However, the precise mechanism underlying cisplatin-associated ototoxicity is still unclear. Nico
Publikováno v:
The Laryngoscope. 129:1462-1467
Objectives/hypothesis To investigate the simultaneous application of cartilage tympanoplasty combined with eustachian tube (ET) balloon dilatation in the treatment of adhesive otitis media (AdOM). Study design Multicenter, prospective, double-blind,
Autor:
Ting, Zhan, Hao, Xiong, Jiaqi, Pang, Weijian, Zhang, Yongyi, Ye, Zhengrong, Liang, Xiaotong, Huang, Feinan, He, Bingquan, Jian, Wuhui, He, Yiming, Gao, Xin, Min, Yiqing, Zheng, Haidi, Yang
Publikováno v:
Toxicology letters. 349
Cisplatin, the most widely used platinum-based anticancer drug, often causes progressive and irreversible sensorineural hearing loss in cancer patients. However, the precise mechanism underlying cisplatin-associated ototoxicity is still unclear. Nico
Autor:
Bingquan Jian, Ting Zhan, Wuhui He, Zhongwu Su, Yiqing Zheng, Huasong Zhang, Weijian Zhang, Hanqing Lin, Jiaqi Pang, Hao Xiong
Publikováno v:
Toxicology letters. 350
Cisplatin-induced hearing loss is a common side effect of cisplatin chemotherapy, for which clinical therapy remains unavailable. Apoptosis of hair cells is considered the primary cause of cisplatin-induced ototoxicity; however, inhibiting apoptosis
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.